CD8A and breast cancer: Inhibition of tumor growth in BC mouse models after systemic treatment with SI-2, which is associated with a decrease of FOXP3+ cells and increase of cytotoxic immune cells (CD8+ T cells, NK cells) and proinflammatory cytokines in the TME.